Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helga Radner

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|July 12, 2015
The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugsHelga Radner, Kazuki Yoshida, Michelle Frits, et al.
Clinical and Experimental Rheumatology|March 14, 2018
Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohortsKarin Britsemmer, Dirkjan van Schaardenburg, Maarten Boers, et al.
European Journal of Immunology|March 17, 2010
Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritisSylvie Trembleau, Markus Hoffmann, Brigitte Meyer, et al.
Annals of the Rheumatic Diseases|February 25, 2022
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trialMichael Bonelli, Helga Radner, Andreas Kerschbaumer, et al.
RMD Open|June 27, 2025
Collecting patient-reported outcomes via the COTIDIANA smartphone app: a prospective validity studyNasim Nakhost Lotfi, Francisco Nunes, Pedro Matias, et al.
Rheumatology (Oxford, England)|June 21, 2019
Comorbidity burden in axial spondyloarthritis: a cluster analysisSizheng Steven Zhao, Helga Radner, Stefan Siebert, et al.
Arthritis Research & Therapy|October 30, 2016
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literatureElena Nikiphorou, Helga Radner, Katerina Chatzidionysiou, et al.
Seminars in Arthritis and Rheumatism|September 27, 2014
Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugsMaria D Mjaavatten, Helga Radner, Kazuki Yoshida, et al.
The Journal of Rheumatology|October 17, 2014
Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysisMaria D Mjaavatten, Helga Radner, Kazuki Yoshida, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple MorbiditiesHelga Radner, Kazuki Yoshida, Sara Tedeschi, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|July 12, 2015
The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugsHelga Radner, Kazuki Yoshida, Michelle Frits, et al.
Clinical and Experimental Rheumatology|March 14, 2018
Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohortsKarin Britsemmer, Dirkjan van Schaardenburg, Maarten Boers, et al.
European Journal of Immunology|March 17, 2010
Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritisSylvie Trembleau, Markus Hoffmann, Brigitte Meyer, et al.
Annals of the Rheumatic Diseases|February 25, 2022
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trialMichael Bonelli, Helga Radner, Andreas Kerschbaumer, et al.
RMD Open|June 27, 2025
Collecting patient-reported outcomes via the COTIDIANA smartphone app: a prospective validity studyNasim Nakhost Lotfi, Francisco Nunes, Pedro Matias, et al.
Rheumatology (Oxford, England)|June 21, 2019
Comorbidity burden in axial spondyloarthritis: a cluster analysisSizheng Steven Zhao, Helga Radner, Stefan Siebert, et al.
Arthritis Research & Therapy|October 30, 2016
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literatureElena Nikiphorou, Helga Radner, Katerina Chatzidionysiou, et al.
Seminars in Arthritis and Rheumatism|September 27, 2014
Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugsMaria D Mjaavatten, Helga Radner, Kazuki Yoshida, et al.
The Journal of Rheumatology|October 17, 2014
Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysisMaria D Mjaavatten, Helga Radner, Kazuki Yoshida, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple MorbiditiesHelga Radner, Kazuki Yoshida, Sara Tedeschi, et al.
Pageof 7